Royal Bank of Canada’s HUMANIGEN, INC. HGEN Stock Holding History

Royal Bank of Canada’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,940	Closed	-$2K	–	7939
2023 Q2	$2K	Buy	10,940 +4,065	+59%	+$632	﹤0.01%	6939
2023 Q1	$1K	Sell	6,875 -4	-0.1%	-$1	﹤0.01%	6991
2022 Q4	$1K	Sell	6,879 -961	-12%	-$139	﹤0.01%	7138
2022 Q3	$1K	Buy	7,840 +965	+14%	+$519	﹤0.01%	7353
2022 Q2	$12K	Sell	6,875 -2,997	-30%	-$6.73K	﹤0.01%	6333
2022 Q1	$30K	Sell	9,872 -7,197	-42%	-$19.3K	﹤0.01%	6386
2021 Q4	$62K	Buy	17,069 +6,390	+60%	+$37.4K	﹤0.01%	6243
2021 Q3	$64K	Buy	10,679 +729	+7%	+$10.2K	﹤0.01%	6013
2021 Q2	$172K	Buy	9,950 +3,050	+44%	+$55.6K	﹤0.01%	5208
2021 Q1	$132K	Buy	6,900 +1,200	+21%	+$21.9K	﹤0.01%	5262
2020 Q4	$100K	Hold	5,700	–	–	﹤0.01%	5348
2020 Q3	$61K	Buy	+5,700	New	+$58.5K	﹤0.01%	5259

Other funds holding HGEN

TCM

Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

DWP

Daymark Wealth Partners Cincinnati, Ohio $4.1B AUM 28.59% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Royal Bank of Canada's HGEN Position: Q3 2023 in Review

Royal Bank of Canada sold out of HUMANIGEN, INC. (HGEN) in Q3 2023, closing a stake of 10,940 shares — an estimated $2K sold.

Royal Bank of Canada first reported a position in HGEN in Q3 2020 and held it in 12 quarters. The position peaked at $172K in Q2 2021. 3 funds tracked by Wall St. Rank hold HGEN as of Q3 2023.

Royal Bank of Canada reported no remaining HUMANIGEN, INC. position as of Q3 2023 after selling out during the quarter.
Royal Bank of Canada sold 10,940 HUMANIGEN, INC. shares in Q3 2023, an estimated $2K.
Royal Bank of Canada first reported a position in HUMANIGEN, INC. in Q3 2020 and held it in 12 quarters.
Royal Bank of Canada's HUMANIGEN, INC. position peaked at $172K in Q2 2021.
3 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2023.

Based on Royal Bank of Canada's 13F filing for Q3 2023, filed 14 Nov 2023.